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Many viruses encode antagonists to prevent interferon (IFN) induction. Infection of fibroblasts with the murine hepatitis coronavirus (MHV)
and SARS-coronavirus (SARS-CoV) did not result in nuclear translocation of interferon-regulatory factor 3 (IRF3), a key transcription factor
involved in IFN induction, and induction of IFN mRNA transcription. Furthermore, MHV and SARS-CoV infection could not prevent IFN
induction by poly (I:C) or Sendai virus, suggesting that these CoVs do not inactivate IRF3-mediated transcription regulation, but apparently
prevent detection of replicative RNA by cellular sensory molecules. Our data indicate that shielding of viral RNA to host cell sensors might be the
main general mechanism for coronaviruses to prevent IFN induction.
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Type 1 interferons (IFN) are soluble cytokines that mediate
an anti-viral state during a wide variety of infections. Their
expression is mainly regulated at the level of transcription
(Haller et al., 2006). Virus infections activate signaling
pathways that eventually result in the production of IFN-β
and IFN-α4 (immediate early IFNs). Molecular pattern
recognition receptors, such as toll-like receptors (TLRs), are
mainly expressed by specialized cells and can be triggered to
initiate IFN production. Non-specialized cells like fibroblasts do
not express these TLRs. For the induction of IFN-mediated
innate immunity, these cells are dependent on the cytoplasmic
RNA helicases retinoic acid-inducible gene I (RIG-I) and
melanoma differentiation-associated gene 5 (MDA-5) (Haller et
al., 2006). The helicases recognize viral RNA and subsequently
activate the IFN-mediated innate immune response. RIG-I⁎ Corresponding author. Fax: +31 715261667.
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doi:10.1016/j.virol.2007.01.020recognizes RNA with unprotected 5′-triphosphates and is
activated upon infection of cells with influenza virus, flavi-
viruses and paramyxoviruses, whereas MDA-5 induces IFN
production in response to double-stranded RNA (dsRNA) such
as during picornavirus infection or transfection with poly (I:C)
(Hornung et al., 2006; Kato et al., 2006; Pichlmair et al., 2006).
Interferon regulatory factors (IRF), such as IRF3, are the key
switches for the transcription regulation of IFN production.
IRF3 is constitutively expressed and localizes exclusively in the
cytoplasm as an inactive monomer in non-infected cells. Upon
infection, IRF3 is phosphorylated, resulting in its dimerization
and subsequent translocation to the nucleus, where it forms a
complex with co-activator p300/CBP to induce IFN-β or IFN-
α4 transcription (Haller et al., 2006).
Coronaviruses (CoV) are positive-stranded RNA viruses
with a genome of approximately 30 kb. Murine hepatitis virus
(MHV) is a group 2 CoV and is closely related to SARS-CoV,
the causative agent of the severe acute respiratory syndrome
(SARS) outbreak (Snijder et al., 2003). Previous studies have
shown that infection of fibroblasts with MHV and SARS-CoV
does not result in a significant induction of IFN production
through intracellular detection by RNA helicases. However,
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IFNs during CoV infection upon recognition of structural
genes of the virus (reviewed in Versteeg and Spaan, in press).
Together, these observations suggest that CoVs prevent IFN
induction and the subsequent activation of antiviral genes.
Recently, it has been shown that SARS-CoV non-structural
protein 1 (nsp1) degrades mRNA, including IFN messengers
(Kamitani et al., 2006) thereby impairing a proper innate
immune response. Here we report that despite accumulation of
dsRNA in infected cells, translocation of IRF3 to the nucleus
does not occur in MHV- and SARS-CoV-infected cells. These
data suggest that the absence of IRF3 activation is a general
characteristic of group 2 coronaviruses. Furthermore we show
that MHV and SARS-CoV do not actively block IRF3 acti-
vation via either RIG-I or MDA-5 as they are unable to inhibit
IRF3 translocation upon Sendai virus infection or poly (I:C)
transfection, respectively.
Results
MHV is unable to prevent IFN induction by poly (I:C) and
Sendai virus
To directly compare transcription induction of immediate
early IFNs by MHV and SARS-CoV, we stably transformed
murine L cells with a plasmid coding for the SARS-CoV
receptor, resulting in a cell line (L-ACE2) that supported
infection with both MHVand SARS-CoV. SARS-CoV infected
100% of the cells and efficiently replicated in L-ACE2 cells,
completing one round of replication in 12 h, similar to the
widely used Vero-E6 cells (data not shown). In 12 h, virus titers
in the medium increased to approximately 5×108 PFU/ml.
L-ACE2 cells were infected at MOI 10 with MHV to address
IFN induction during infection. At 8 h p.i., intracellular RNA
was isolated and IFN-α4 mRNA concentrations were deter-
mined by RT–qPCR. Despite efficient MHV progeny virus
production (data not shown), MHV infection did not result in
IFN-α4 (Fig. 1A) or IFN-β mRNA (data not shown) upregula-
tion. Infection with different MHV strains (MHV-2, -JHM) in
other cell lines (DBT, WBC264-9) did not trigger IFN
transcription either (data not shown). As a control for IFN-α4
mRNA induction, mock-infected cells were transfected with
poly (I:C). Poly (I:C) treatment resulted in an increase of IFN-α4
mRNA levels by approximately 280-fold (Fig. 1A), showing
that these cells can be readily stimulated to initiate transcription
of IFN genes. Next, MHV-infected cells were transfected with
poly (I:C) to determine if MHV could actively prevent IFN
induction throughMDA-5-mediated IRF3 activation. Activation
of IRF3 results in translocation of IRF3 to the nucleus which is a
prerequisite for early IFN induction. In mock- and MHV-
infected cells that were transfected with poly (I:C), a comparable
fraction of the cells (85%) showed nuclear IRF3 translocation by
IFA (Fig. 1B). Approximately 60–65% of those cells were
infected with MHV, indicating that MHV cannot prevent IRF3
translocation to the nucleus and that it does not affect the ratio of
cells displaying nuclear translocated IRF3. Moreover, poly (I:C)
transfection stimulated IFN-α4 transcription to similar levels asin non-infected cells (Fig. 1A). Although more than 90% of all
cells were MHV-infected after control transfection, the percen-
tage of infected cells was reduced to approximately 60% after
poly (I:C) treatment (Fig. 1B), indicating that although MHV
infection can be established after poly (I:C) treatment, MHVis to
some extent sensitive to IFN induction. Together, these data
demonstrated that early IFNs were not induced by MHV
infection and that MHV was unable to counteract IFN induction
through MDA-5 by poly (I:C).
To determine whetherMHVactively inhibited IRF3 signaling
through RIG-I, L-ACE2 cells were infected with both MHVand
SeVat an MOI of 5. Nuclear localization of IRF3 was analyzed
by IFA in either MHV, SeVor MHV-SeV doubly infected cells.
As shown in Fig. 1D, IRF3 was exclusively localized in the
cytoplasm of cells that were infected with MHVonly. This result
is not due to impairment of IRF3 translocation in these particular
cells since IRF3 translocated to the nuclei of SeV-infected cells,
both in the absence and presence of MHV (Fig. 1D). Overall,
70% of the cells were infected with SeV and showed nuclear
translocation of IRF3. Of those cells, 90%was also infected with
MHV (Fig. 1D), indicating that MHV was unable to interfere
with the nuclear translocation of IRF3 in cells that were infected
with both MHV and SeV. The IFN-α4 mRNA levels in these
doubly infected cells were comparable to cells infected with only
SeV (Fig. 1C). Taken together, the data presented in Fig. 1
clearly demonstrated that MHV infection could not induce or
prevent the RIG-I- or MDA-5-mediated immediate early IFN
responses.
SARS-CoV is unable to prevent IFN induction by poly (I:C) and
Sendai virus
To confirm that SARS-CoV did not induce IFN in L-ACE2
cells and that the lack of IFN induction is a general feature of
group 2 CoVs, we subsequently analyzed whether SARS-CoV
was able to induce IFN production in L-ACE2 cells.
Intracellular RNA was isolated and the induction of IFN-α4
was determined by RT–qPCR. Comparable to MHV-infected
L-ACE2 cells, SARS-CoV-infected cells showed no increase
in IFN-α4 (Figs. 2A/D) and IFN-β mRNA concentrations
(data not shown) compared to mock-infected cells. Next, the
ability of SARS-CoV to interfere with MDA-5 activated IFN
responses when stimulated with poly (I:C) was investigated.
L-ACE2 cells were infected with SARS-CoV at MOI 5 and
subsequently transfected with poly (I:C). No IFN induction
occurred during SARS-CoV infection. However, treatment
with poly (I:C) stimulated IFN-α4 mRNA concentrations by
900-fold in both mock- as well as SARS-CoV-infected cells
(Fig. 2A), suggesting that no interference by the virus
occurred. A similar percentage of the cells was transfected
with poly (I:C) as indicated by nuclear IRF3 localization in
both mock- and SARS-CoV-infected samples (Fig. 2B),
further illustrating the lack of interference with IFN induction
by SARS-CoV. SARS-CoV replicative proteins were readily
detected in one-third of the cells with nuclear IRF3, further
indicating that SARS-CoV did not significantly prevent IRF3
translocation (Fig. 2B).
20 Rapid CommunicationSubsequently, L-ACE2 cells were infected with both SeV
and SARS-CoV at an MOI of 1 to establish whether SARS-
CoV could actively inhibit IFN mRNA synthesis through RIG-Fig. 1. L-ACE2 cells were infected with MHV at MOI 10. At 1 h p.i., cells were tr
transcribed using random hexamers. (A) IFN-α4 mRNA concentration was determi
nucleocapsid protein were detected in IFAwith specific poly- and monoclonal antibod
cells were seeded on coverslips in 35-mm wells and infected with SeV for 30 min. Ne
fixed in 3% paraformaldehyde. From the remainder of the cells, total RNA was
concentration was determined using specific RT–qPCR and (D) endogenous IRF3
monoclonal antibodies, respectively. Nuclear IRF3 is indicated with arrows.I. At 12 h p.i., RNAwas isolated. As determined by RT–qPCR,
SeV infection of L-ACE2 cells resulted in an 80-fold IFN-α4
mRNA increase at 12 h p.i. compared to mock-infected cellsansfected with 4 μg poly (I:C). At 8 h p.i. total RNA was isolated and reverse
ned using specific RT–qPCR and (B) endogenous IRF3 localization and MHV
ies, respectively. Nuclear IRF3 is indicated with arrows. Subsequently, L-ACE2
xt, cells were infected with MHVat MOI 5. At 8.5 h p.i. cells on coverslips were
isolated and reverse transcribed using random hexamers. (C) IFN-α4 mRNA
and MHV nucleocapsid protein were detected in IFA with specific poly- and
Fig. 1 (continued ).
21Rapid Communication(Fig. 2D). SARS-CoV infection did not reduce IFN-α4 mRNA
induction in L-ACE2 cells by SeV (Fig. 2D) compared to SeV
infection only. IRF3 translocation to the nucleus was
determined by IFA, to establish whether the lack of IFN-α4
induction in SARS-CoV-infected cells resulted from absence of
IRF3 translocation to the nucleus. In mock- and SARS-CoV-
infected cells IRF3 resided in the cytoplasm, while in SeV or
SARS-CoV and SeV doubly infected cells IRF3 was
translocated to the nucleus (Fig. 2C). Approximately 65% of
those cells were doubly infected (Fig. 2C), indicating that
SARS-CoV does not interfere with nuclear IRF3 localization inSeV-infected cells and does not influence the percentage of
cells with nuclear IRF3.
dsRNA accumulates in SARS-CoV- and MHV-infected cells
It has been suggested that low levels of dsRNA in CoV-
infected cells could be the reason for lack of IFN induction,
rather than interference with components of the IFN induction
pathways (Sawicki and Sawicki, 2005). To determine the
formation of dsRNA during viral replication, L-ACE2 cells
infected with either MHV or SARS-CoV were fixed at 8 and
22 Rapid Communication12 h p.i.. The presence of dsRNA in MHV- or SARS-CoV-
infected cells was determined by IFA using a dsRNA-specific
antibody. No signal was observed in mock-infected cells, while
dsRNA was detected in both MHV- and SARS-CoV-infected
cells (Fig. 3), indicating the production of significant amounts
of dsRNA during CoV infection.Fig. 2. L-ACE2 cells were infected with SARS-CoVat MOI 5. At 1 h p.i., cells were
transcribed using random hexamers. (A) IFN-α4 mRNA concentration was determin
CoV nsp3 protein were detected in IFAwith specific antibodies. Nuclear IRF3 is indic
CoV at MOI 1. At 12 h p.i. total RNA was isolated and reverse transcribed using ra
localization and SARS-CoV nsp3 protein were analyzed by immunofluorescence.
determined using specific RT–qPCR.Discussion
The results reported here demonstrated that infection with
MHVand SARS-CoV does not induce immediate early IFNs in
fibroblast-like cells. We conclude that viral RNA in CoV-
infected cells is not recognized by cellular sensors based on thetransfected with 4 μg poly (I:C). At 8 h p.i. total RNAwas isolated and reverse
ed using specific RT–qPCR and (B) endogenous IRF3 localization and SARS-
ated with arrows. Subsequently, L-ACE2 cells were infected with SeVor SARS-
ndom hexamers and coverslips were fixed in 3% paraformaldehyde. (C) IRF3
Nuclear IRF3 is indicated with arrows. (D) IFN-α4 mRNA concentration was
Fig. 2 (continued ).
23Rapid Communicationfollowing observations: (i) nuclear IRF3 translocation or IFN
mRNA transcription was not triggered during MHVand SARS-
CoV infection despite the presence of dsRNA and (ii) MHVand
SARS-CoV could not interfere with nuclear IRF3 translocation
and IFN induction through RIG-I by SeVor through MDA-5 by
poly (I:C). Viruses have evolved multiple mechanisms to
prevent or inactivate IFN-mediated antiviral immunity at the
level of IRF3 activation (Haller et al., 2006). For example,influenza virus NS1 and E3L from poxviruses are dsRNA
binding proteins that prevent IRF3 activation by sequestering
viral RNA and thereby circumvent recognition by RIG-I and
MDA-5. The V protein of several paramyxoviruses interacts
directly with MDA-5 and prevents as such IRF3 activation and
subsequent IFN induction. The hepatitis C virus protease NS3/
4A cleaves the adaptor molecule VISA. The P protein of
Borna disease virus (BDV) inhibits IRF3 phosphorylation by
Fig. 3. L-ACE2 cells were infected with MHVor SARS-CoVat MOI 10 and 1, respectively. At 8 h after MHV infection or 12 h after SARS-CoV infection, cells were
fixed in 3% paraformaldehyde. MHV and SARS-CoV were detected in IFA using specific polyclonal antibodies raised against MHV virions and SARS-CoV N
protein, respectively. dsRNA was detected in IFA with specific monoclonal antibodies.
24 Rapid Communicationaverting proper functioning of kinase TBK1 (Haller et al., 2006).
Importantly, hepatitis A virus infection has been reported to
interfere with IRF3 translocation and IFN production induced by
poly (I:C) and an exogenous virus, very similar to the approach
described in this manuscript (Fensterl et al., 2005). These viruses
all actively interfere with the IFN induction pathway, rather than
preventing its initial activation. However, our data indicate that
MHV, SARS-CoV and possibly other group 2 CoVs have
devised a yet undescribed mechanism where viral RNA is
protected from the host cell's sensory molecules.
MHV replication requires ongoing viral protein synthesis
(Sawicki and Sawicki, 2005). In contrast to e.g. alphaviruses,
MHV replication complexes are unstable and replication is
marked by high turn-over of minus-strand RNA, whereas plus-
strand RNA is relatively stable (Sawicki and Sawicki, 2005).
The unstable nature of the minus-strand RNA has been
suggested to prevent the formation of stable dsRNA replicative
intermediates/forms and subsequent triggering of the IFN
response through MDA-5 (Sawicki and Sawicki, 2005).
Immunofluorescence labeling with a dsRNA-specific antibody
(Fig. 3) strongly suggests that significant amounts of dsRNA are
formed during CoV infection and that rapid turn-over of minus-
strand RNA is unlikely to explain the lack of IFN induction.
Since substantial amounts of dsRNA are present in infected cells
(Fig. 3), our data suggest that an additional form of protection of
the dsRNA underlies the lack of IRF3 activation and IFN RNA
synthesis (Figs. 1 and 2). In comparison to MDA-5, RIG-I-
mediated IFN induction depends on 5′-triphosphates rather than
dsRNA (Hornung et al., 2006; Pichlmair et al., 2006). dsRNA
without 5′-triphosphates like poly (I:C), picornavirus RNA
which contains VPg at the 5′-end or capped RNAs do not trigger
IFN responses through RIG-I, but utilize MDA-5 (Kato et al.,
2006). Coronavirus RNA is capped during replication by which
RIG-I induction could be prevented (Lai et al., 1982). Since viralRNA synthesis occurs in the cytoplasm and host cell RNA
modifications such as capping occur in the nucleus, many
viruses have devised strategies to provide their own RNA
modification machinery. All group 2 coronaviruses encode five
homologs of cellular enzymes involved in RNA processing
(Snijder et al., 2003). One of them is a 2′-O-methyltransferase
which could play a role in capping of the viral RNA.
The nature of the replication complex could create a
compartment that prevents replicating RNA from being
detected by the host cell. CoV replication complexes are
associated with host cell membranes which could create such an
environment. Although this is a general feature of all other
positive-stranded RNA viruses, association with double mem-
brane vesicles (DMV) has exclusively been reported for corona-
and picornaviruses so far (Gosert et al., 2002; Snijder et al.,
2006). These DMVs could facilitate replication by compart-
mentalizing replication factors and providing structural support
for membrane anchoring. Furthermore, DMVs could form a
protective microenvironment that prevents viral RNA from
being detected by host cell sensors. The fact that picornaviruses
have also devised other mechanisms to actively interfere with
correct induction and functioning of the IFN response (Haller et
al., 2006) suggests that the formation of DMVs is apparently not
sufficient to prevent IFN induction per se. Current knowledge
on the similarities of the DMVs of these two virus families is
insufficient to establish whether differential organization of
CoV and picornavirus DMVs could explain these different
properties. A recent report by Kato and co-workers suggested
that viruses within the same families trigger IFN responses
through the same pathway (Kato et al., 2006). We demonstrated
that MHV does not interfere with the RIG-I or MDA-5 pathway.
However, we cannot rule out that CoVs induce IFN responses
through other cellular molecules than RIG-I or MDA-5 at this
point. Although CoVs may express proteins that affect IFN
25Rapid Communicationinduction when expressed separately, here we demonstrate that
in the context of virus infection, CoVs do not significantly
interfere directly with IRF3 translocation or IFN transcription.
However, Spiegel and co-workers have reported nuclear IRF-3
localization during SARS-CoV infection (Spiegel et al., 2005).
It is currently unclear what underlies the discrepancy with our
data. Their infections were performed using another SARS-
CoV strain (FFM1) and different cells (a selected 293-cell
clone) what may explain the differences. Similar results to ours
showing the inability of MHV-A59 to interfere with MDA-5- or
RIG-I-mediated IFN induction were recently published (Zhou
and Perlman, 2007). The results presented in our work confirm
and support those findings. The new data on SARS-CoV
provide evidence that all group 2 CoVs may employ a similar
mechanism to prevent IFN induction.
Infection of fibroblasts with MHV and SARS-CoV does not
result in a significant IFN production. However, specialized
cells that express TLRs are triggered to produce IFN during
CoV infection (reviewed in Versteeg and Spaan, 2006).
Furthermore, plasmatoid dendritic cells (pDC) are the pre-
dominant cells to produce systemic IFN during MHV infection
in vivo (Cervantes-Barragan et al., 2007). The experiments
described in this paper were all performed in non-specialized
(immune) cells. Although the significance of the absence of IFN
induction in these cells remains to be established, we
hypothesize that it could give the virus a temporal advantage




Mouse L cells and Sac− cells were cultured and infected with
MHV as described before (Jacobs et al., 1981). L cells stably
expressing the SARS-CoV receptor angiotensin converting
enzyme 2 (L-ACE2) were constructed by transformation of L
cells with plasmid pcDNA3/FLACE2 (Broer et al., 2006). Full
details will be published elsewhere. L-ACE2 cells were
maintained as regular L cells, with the only exception that the
medium was supplemented with 500 μg/ml G418. Strain A59 of
MHV was obtained from ATCC. SARS-CoV strain Frankfurt 1
was grown on Vero-E6 cells and all work with infectious SARS-
CoV was performed as described (Snijder et al., 2006). MOI 1–
10 was used for coronavirus infections throughout this study.
MHV and SARS-CoV titers were determined by plaque assays
on L cells and L-ACE2 cells, respectively. Recombinant Sendai
virus H4 (SeV-H4) (Cadd et al., 1996) was kindly provided by
D. Kolakofsky. SeV-H4 infections were carried out in complete
medium for 30–45 min at 37 °C after which complete medium
was added to the inoculum.
RNA isolation and quantitative RT–PCR
Total RNAwas isolated from cells at the indicated times p.i.
using TRIzol reagent (Invitrogen). RNAwas treated with 2 units
of DNaseI (Invitrogen) at 37 °C for 30 min to remove potentialDNA contamination. Quantitative RT–PCR (RT–qPCR) was
performed as described previously (Versteeg et al., 2006).
Primer sequences are available on request.
IFN induction by poly (I:C)
L-ACE2 cells were washed with phosphate-buffered saline
(PBS) and infected with MHV or SARS-CoV in DMEM
containing 3% FCS. At 1 h p.i., cells were washed with PBS and
transfected with 4 μg poly (I:C) (Sigma) using Lipofectamine
2000 (Invitrogen) as recommended by the manufacturer.
Subsequently, cells were incubated for another 7 h at 37 °C.
Antisera and immunofluorescence assay
Cells were seeded on glass coverslips in 35-mm wells,
infected and subsequently transfected as described above.
Coverslips were removed at set intervals, fixed in 3%
paraformaldehyde and further processed for immunofluores-
cence assay as described previously (Snijder et al., 2006). Cells
were incubated with either 1:1000 diluted rabbit k134 serum
raised against MHV particles (Rottier et al., 1981), 1:400
diluted anti-IRF3 (Zymed), 1:400 diluted 5B188.2 anti-MHV N
(Talbot et al., 1984), 1:500 diluted anti-SARS-CoV nsp-3 di-
rectly coupled to Alexa Fluor 488 dye (Snijder et al., 2006) or
1:400 diluted anti-dsRNA antibody (Weber et al., 2006).
Samples were examined with a Zeiss Axioskop 2 fluorescence
microscope. Monoclonal antibodies were detected using Alexa
Fluor 488-conjugated goat anti-mouse secondary antibodies
(Invitrogen). Polyclonal antibodies were detected with Cy3-
conjugated donkey anti-rabbit secondary antibodies (Invitro-
gen). Nuclei were labeled by DNA staining using Hoechst
33342 dye.
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